VSEE

+ Watchlist + Portfolio

VSee Health, Inc.

Recurring revenue Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.25
52-Week Range: $0.02 – $201.60
Market Cap: $1.49M
P/E (TTM): —
EPS (TTM): -42.51
Dividend Yield: —

Advanced Metrics

Price/Book: 15.46
PEG Ratio: —
Return on Equity: -1455.88%
Return on Assets: -38.76%
Gross Margin: 43.43%
Operating Margin: -172.70%
Profit Margin: -62.59%
Current Ratio: 0.40
Debt/Equity: 0.27
Total Debt: $2.02M
Free Cash Flow: $-9.33M
Revenue Growth: 48.00%
Earnings Growth: —
Enterprise Value: $103.59M

VSEE Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$6.38M	$5.77M	$10.42M	$14.62M
Cost of Revenue	$1.54M	$1.93M	$3.24M	$7.26M
Gross Profit	$4.84M	$3.83M	$7.18M	$7.36M
Selling, General & Admin	$6.30M	$5.62M	$11.86M	$16.94M
Operating Expenses	$6.30M	$5.62M	$11.86M	$16.94M
Operating Income	-$1.46M	-$1.79M	-$4.68M	-$9.58M
EBITDA	-$1.59M	-$1.69M	-$57.75M	-$9.18M
Pretax Income	-$1.62M	-$1.89M	-$59.34M	-$14.64M
Income Tax	-$694.36K	$1.84M	-$1.64M	$68.43K
Net Income	-$836.21K	-$3.76M	-$57.70M	-$14.71M
Diluted EPS	-0.06	-0.26	—	-0.73
Diluted Shares	14.69M	14.69M	—	20.14M

VSEE Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$230.66K	$118.73K	$326.12K	$5.27M
Receivables	$389.45K	$603.48K	$2.25M	$2.83M
Current Assets	$759.78K	$802.13K	$3.02M	$8.37M
Total Assets	$2.61M	$805.79K	$19.99M	$22.41M
Current Liabilities	$2.61M	$5.11M	$19.01M	$16.24M
Total Debt	$517.13K	$543.00K	$9.55M	$3.26M
Total Liabilities	$2.61M	$5.11M	$20.01M	$16.96M
Retained Earnings	-$5.67M	-$10.00M	-$67.70M	-$82.42M
Shareholders' Equity	$360.72K	-$3.97M	-$18.49K	$5.45M
Working Capital	-$1.85M	-$4.30M	-$15.99M	-$7.88M
Net Debt	$286.47K	$424.27K	$7.96M	—

VSEE Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$825.78K	-$632.60K	-$5.79M	-$3.45M
Capital Expenditure	—	-$4.33K	-$55.27K	-$29.93K
Free Cash Flow	-$825.78K	-$636.93K	-$5.84M	-$3.48M
Depreciation & Amortisation	—	$678.00	$1.38M	$2.65M
Stock-Based Compensation	—	$0.00	$896.54K	$1.12M
Investing Cash Flow	—	-$4.33K	-$26.14K	-$29.93K
Financing Cash Flow	$710.00K	$525.00K	$6.02M	$8.42M
Net Change in Cash	-$115.78K	-$111.93K	$207.38K	$4.94M

VSEE Income statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$3.86M	—	$1.06M	$3.98M	$3.93M	$3.16M	$1.56M
Cost of Revenue	$1.43M	—	$440.15K	$1.91M	$2.09M	$1.96M	$1.36M
Gross Profit	$2.43M	—	$615.04K	$2.07M	$1.83M	$1.20M	$206.15K
Selling, General & Admin	$5.54M	—	$2.17M	$4.13M	$5.27M	$4.17M	$2.90M
Operating Expenses	$5.54M	—	$2.17M	$4.13M	$5.27M	$4.17M	$2.90M
Operating Income	-$3.11M	—	-$1.56M	-$2.06M	-$3.44M	-$2.97M	-$2.70M
EBITDA	-$4.14M	—	-$1.02M	$1.14M	-$6.07M	-$1.81M	-$2.37M
Pretax Income	-$4.47M	—	-$1.90M	-$289.75K	-$7.80M	-$2.58M	-$3.10M
Income Tax	$1.15M	—	$1.73K	$0.00	$50.44K	$23.74K	-$17.90K
Net Income	-$5.62M	—	—	-$289.75K	-$7.85M	-$2.60M	$847.27K
Diluted EPS	—	—	—	-0.02	—	-0.05	0.01
Diluted Shares	—	—	—	16.55M	—	47.90M	55.78M

VSEE Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	—	—	—	$472.76K	$5.27M	$1.35M	$454.15K
Receivables	—	—	—	$2.86M	$2.83M	$2.98M	$2.55M
Current Assets	—	—	—	$3.72M	$8.37M	$4.84M	$3.27M
Total Assets	—	—	—	$18.71M	$22.41M	$19.02M	$16.73M
Current Liabilities	—	—	—	$23.42M	$16.24M	$11.79M	$8.10M
Long-Term Debt	—	—	$593.94K	—	—	$781.58K	$781.58K
Total Debt	—	—	—	$10.88M	$3.26M	$2.14M	$2.17M
Total Liabilities	—	—	—	$24.28M	$16.96M	$12.70M	$9.14M
Retained Earnings	—	—	—	-$74.57M	-$82.42M	-$85.02M	-$84.17M
Shareholders' Equity	—	—	—	-$5.58M	$5.45M	$6.32M	$7.59M
Working Capital	—	—	—	-$19.70M	-$7.88M	-$6.95M	-$4.83M
Net Debt	—	—	$11.74M	$9.34M	—	$778.14K	$1.56M

VSEE Cash Flow statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$2.97M	—	—	-$754.54K	-$1.93M	-$2.45M	-$1.17M
Capital Expenditure	-$4.76K	—	—	-$7.31K	-$7.15K	-$26.75K	—
Free Cash Flow	-$2.98M	—	-$312.73K	-$777.31K	-$1.93M	-$2.48M	-$1.15M
Depreciation & Amortisation	$709.96K	—	$664.00K	$674.00K	$648.22K	$649.04K	$642.72K
Stock-Based Compensation	$515.45K	—	—	$0.00	$360.48K	$441.31K	$202.56K
Investing Cash Flow	-$4.76K	—	—	-$7.31K	-$7.15K	-$126.75K	-$2.00K
Financing Cash Flow	$977.83K	—	—	$943.01K	$6.73M	-$1.34M	$498.58K
Net Change in Cash	-$2.00M	—	—	$181.16K	$4.79M	-$3.92M	-$677.14K

Market Snapshot

About

VSee Health, Inc. is a telehealth technology company that provides secure video communication and telemedicine platforms for healthcare delivery. The company offers solutions for virtual consultations, remote patient monitoring, and clinical workflows used by healthcare providers, hospitals, and government health programs. VSee focuses on enabling accessible, high-quality healthcare through digital communication technologies.